-->

Acumen Pharmaceuticals Stock Equity Positions Weight

ABOS Stock  USD 1.35  0.05  3.57%   
Fundamental analysis of Acumen Pharmaceuticals allows traders to better anticipate movements in Acumen Pharmaceuticals' stock price by examining its financial health and performance throughout various phases of its business cycle.
  
Build AI portfolio with Acumen Stock
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Acumen Pharmaceuticals Company Equity Positions Weight Analysis

Acumen Pharmaceuticals' Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.

Stock Percentage

 = 

% of Equities

in the fund

More About Equity Positions Weight | All Equity Analysis

Acumen Equity Positions Weight Driver Correlations

Understanding the fundamental principles of building solid financial models for Acumen Pharmaceuticals is extremely important. It helps to project a fair market value of Acumen Stock properly, considering its historical fundamentals such as Equity Positions Weight. Since Acumen Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Acumen Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Acumen Pharmaceuticals' interrelated accounts and indicators.
0.990.95-0.56-0.880.660.610.320.991.00.990.570.630.730.830.38-0.48
0.990.96-0.62-0.850.610.520.181.00.990.990.510.60.660.80.34-0.42
0.950.96-0.56-0.920.770.630.20.960.960.950.660.410.680.790.54-0.6
-0.56-0.62-0.560.25-0.030.210.24-0.57-0.62-0.650.11-0.090.11-0.310.16-0.19
-0.88-0.85-0.920.25-0.93-0.86-0.45-0.87-0.86-0.84-0.86-0.43-0.88-0.88-0.710.81
0.660.610.77-0.03-0.930.920.50.630.640.60.960.140.820.720.87-0.95
0.610.520.630.21-0.860.920.720.560.560.530.910.350.910.680.82-0.9
0.320.180.20.24-0.450.50.720.220.280.240.560.340.660.430.34-0.54
0.991.00.96-0.57-0.870.630.560.220.990.990.540.620.70.820.35-0.45
1.00.990.96-0.62-0.860.640.560.280.991.00.530.60.680.810.37-0.44
0.990.990.95-0.65-0.840.60.530.240.991.00.490.610.640.790.35-0.4
0.570.510.660.11-0.860.960.910.560.540.530.490.10.870.720.74-0.99
0.630.60.41-0.09-0.430.140.350.340.620.60.610.10.560.550.00.0
0.730.660.680.11-0.880.820.910.660.70.680.640.870.560.820.56-0.82
0.830.80.79-0.31-0.880.720.680.430.820.810.790.720.550.820.39-0.61
0.380.340.540.16-0.710.870.820.340.350.370.350.740.00.560.39-0.8
-0.48-0.42-0.6-0.190.81-0.95-0.9-0.54-0.45-0.44-0.4-0.990.0-0.82-0.61-0.8
Click cells to compare fundamentals
Funds with most asset allocated to stocks can be subclassified into many different categories such as market capitalization or investment style.
Competition

According to the company disclosure, Acumen Pharmaceuticals has an Equity Positions Weight of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Acumen Pharmaceuticals Current Valuation Drivers

We derive many important indicators used in calculating different scores of Acumen Pharmaceuticals from analyzing Acumen Pharmaceuticals' financial statements. These drivers represent accounts that assess Acumen Pharmaceuticals' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Acumen Pharmaceuticals' important valuation drivers and their relationship over time.
202020212022202320242025 (projected)
Market Cap575.9M135.6M219.3M103.2M118.7M112.8M
Enterprise Value532.1M13.4M89.3M97.3M111.9M106.3M

Acumen Fundamentals

About Acumen Pharmaceuticals Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Acumen Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Acumen Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Acumen Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Acumen Stock Analysis

When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.